Centrexion Therapeutics Announces CNTX-4975 Data Presentations at the 2019 British Society for Rheumatology Annual Conference and Osteoarthritis Research Society International 2019 World Congress

NEXT STORY
Precipio Signs First Major International Services Contract
PREV STORY
U.S. FDA accepts New Drug Application for review and grants Priority Review for darolutamide
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Cellceutix Reports Advances in Developing Kevetrin as an Oral Ovarian Cancer Treatment; Company Seeks to Develop World’s First p53-Modulating Oral Cancer Drug

BEVERLY, Mass., Dec. 15, 2016 (GLOBE NEWSWIRE) -- Cellceutix Corporation, (OTCQB:CTIX) (“the Company”), a ...

author_avatar
NASDAQ Market News

Real Good Foods Launches National Diabetes Awareness Month Campaign

Partnering with Beyond Type 1 during November to raise donationsLos Angeles, California, Nov. 01, ...

author_avatar
NASDAQ Market News

The $28+ Billion Worldwide Market for Rapid Diagnostic Kits (2018-2023)

Dublin, Dec. 19, 2018 (GLOBE NEWSWIRE) -- The "Global Rapid Diagnostic Kits Market - ...

author_avatar
NASDAQ Market News